Overview of the Guarantee Situation
Guangdong Baolait Medical Technology Co., Ltd. (hereinafter referred to as "the Company") held its eighth meeting of the ninth board of directors on April 24, 2026, and the 2025 annual shareholders' meeting on May 15, 2026. The proposal regarding the Company and its subsidiaries applying for comprehensive credit limits from banks and other financial institutions and providing guarantees for subsidiaries was approved. The Company agreed to provide guarantees for certain subsidiaries when applying for comprehensive credit, financing leases, and other financing activities. Specifically, the Company will provide a guarantee of no more than RMB 30 million (or equivalent foreign currency) for its wholly-owned subsidiary, Shenzhen Baoyuan Medical Devices Co., Ltd. (hereinafter referred to as "Shenzhen Baoyuan"), when applying for comprehensive credit and financing leases from financial institutions. The guarantee period is effective from the date of approval by the shareholders' meeting until the next annual shareholders' meeting that reviews the guarantee limit. The guarantee balance at any point in time shall not exceed the approved guarantee limit. The specific content of the credit and guarantee is subject to the relevant agreements signed with financial institutions. The chairman or their authorized agent is authorized to handle related business and sign relevant agreements and other legal documents within the scope and validity period of the guarantee limit. For detailed information, please refer to the announcement disclosed by the Company on April 25, 2026, on the Giant Tide Information Network (www.cninfo.com.cn) titled "Announcement on the Company and Subsidiaries Applying for Comprehensive Credit Limits from Banks and Providing Guarantees for Subsidiaries" (Announcement No.: 2026-021).